Low serum thyrotropin is associated with high plasma fibrinogen

被引:63
作者
Dörr, M
Robinson, DM
Wallaschofski, H
Schwahn, C
John, U
Felix, SB
Völzke, H
机构
[1] Univ Greifswald, Dept Internal Med B, D-17487 Greifswald, Germany
[2] Univ Greifswald, Dept Internal Med A, D-17487 Greifswald, Germany
[3] Univ Greifswald, Sch Dent, D-17487 Greifswald, Germany
[4] Univ Greifswald, Inst Epidemiol & Social Med, D-17487 Greifswald, Germany
关键词
D O I
10.1210/jc.2005-1786
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Elevated plasma fibrinogen levels are associated with an increased risk of cardiovascular events. Decreased serum TSH predicts vascular mortality, which hypothetically could be explained in part by alterations in the blood coagulation system. Objective: The objective of this study was to investigate the association between thyroid function and plasma fibrinogen levels in a general population. Design: The population-based Study of Health in Pomerania was performed in a previously iodine-deficient area in Germany, including 4310 subjects, aged 20-79 yr. Data for 3804 individuals without thyroid disease were analyzed. Analysis revealed an association between thyroid function status and plasma fibrinogen concentration. Results: Elevated fibrinogen levels (> 3.25 g/liter) were observed in 14 subjects with increased serum TSH levels (32.6%), 973 euthyroid subjects (28.9%), 158 subjects with decreased serum TSH levels (40.7%), and six individuals with overt hyperthyroidism (54.4%). Logistic regression analysis revealed decreased serum TSH as an independent risk factor for elevated fibrinogen levels (odds ratio, 1.42; 95% confidence interval, 1.12-1.80). Conclusions: Thyroid function is associated with plasma fibrinogen. Decreased serum TSH is an independent risk factor for elevated plasma fibrinogen levels as a possible explanation for the high cardiovascular mortality among affected subjects.
引用
收藏
页码:530 / 534
页数:5
相关论文
共 25 条
[1]   Effects of subclinical thyroid dysfunction on the heart [J].
Biondi, B ;
Palmieri, EA ;
Lombardi, G ;
Fazio, S .
ANNALS OF INTERNAL MEDICINE, 2002, 137 (11) :904-914
[2]   Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol [J].
Burggraaf, J ;
Lalezari, S ;
Emeis, JJ ;
Vischer, UM ;
de Meyer, PHEM ;
Pijl, H ;
Cohen, AF .
THYROID, 2001, 11 (02) :153-160
[3]   Relationship between thyroid hormones and fibrinogen levels [J].
Chadarevian, R ;
Bruckert, E ;
Giral, P ;
Turpin, G .
BLOOD COAGULATION & FIBRINOLYSIS, 1999, 10 (08) :481-486
[4]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[5]   The association of thyroid function with cardiac mass and left ventricular hypertrophy [J].
Dörr, M ;
Wolff, B ;
Robinson, DM ;
John, U ;
Lüdemann, J ;
Meng, W ;
Felix, SB ;
Völzke, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (02) :673-677
[6]   Blood coagulation and fibrinolysis in patients with hyperthyroidism [J].
Erem, C ;
Ersoz, HÖ ;
Karti, SS ;
Ukinç, K ;
Hacihasanoglu, A ;
Deger, O ;
Telatar, M .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2002, 25 (04) :345-350
[7]   POPULATION CORRELATES OF PLASMA-FIBRINOGEN AND FACTOR-VII, PUTATIVE CARDIOVASCULAR RISK-FACTORS [J].
FOLSOM, AR ;
WU, KK ;
DAVIS, CE ;
CONLAN, MG ;
SORLIE, PD ;
SZKLO, M .
ATHEROSCLEROSIS, 1991, 91 (03) :191-205
[8]   Consensus statement: Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society [J].
Gharib, H ;
Tuttle, RM ;
Baskin, HJ ;
Fish, LH ;
Singer, PA ;
McDermott, MT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :581-585
[9]   Coagulation disorders in thyroid diseases [J].
Hofbauer, LC ;
Heufelder, AE .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1997, 136 (01) :1-7
[10]   Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994):: National Health and Nutrition Examination Survey (NHANES III) [J].
Hollowell, JG ;
Staehling, NW ;
Flanders, WD ;
Hannon, WH ;
Gunter, EW ;
Spencer, CA ;
Braverman, LE .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) :489-499